Valneva Publishes its FY 2020 Audited Consolidated Financial Statements
24 Marzo 2021 - 7:00AM
Saint-Herblain (France), March 24, 2021 –
Valneva SE (“Valneva” or “the Company”), a specialty vaccine
company focused on the development and commercialization of
prophylactic vaccines for infectious diseases with significant
unmet medical need, announced today the publication of its 2020
audited consolidated financial statements. Valneva previously
reported its unaudited 2020 financial results on February 25,
20211.
The 2020 audited consolidated financial
statements, which include the amount of fees paid to the auditors,
are available on the Company’s website
(https://valneva.com/investors/financial-reports/).
In addition to the annual consolidated financial
statements, Valneva has published its 2020 Annual Business Report
in an online format. The report features a video address from CEO
Thomas Lingelbach commenting on Valneva’s 2020 performance. The
2020 Annual Business Report is available at
www.ValnevaAnnualBusinessReport.com, as well as through the
Company’s website.
About Valneva SEValneva is a
specialty vaccine company focused on the development and
commercialization of prophylactic vaccines for infectious diseases
with significant unmet medical need. We take a highly specialized
and targeted approach to vaccine development, beginning with the
identification of deadly and debilitating infectious diseases that
lack a prophylactic vaccine solution and for which there are
limited therapeutic treatment options. We then apply our deep
understanding of vaccine science, including our expertise across
multiple vaccine modalities, as well as our established vaccine
development capabilities, to develop prophylactic vaccines to
address these diseases. We have leveraged our expertise and
capabilities both to successfully commercialize two vaccines and to
rapidly advance a broad range of vaccine candidates into and
through the clinic, including candidates against Lyme disease, the
chikungunya virus and COVID-19.
Valneva
Investor and Media ContactsLaetitia
Bachelot-FontaineDirector Investor Relations & Corporate
CommunicationsM +33 (0)6 4516
7099investors@valneva.com |
Teresa
PinzolitsCorporate Communications SpecialistT +43 (0)1 20620
1116communications@valneva.com |
1 Valneva Reports FY 2020 Results and Major Corporate
Achievements
-
2020_03_24_VLA_FY2020_Audited_Consolidated_Financial_Statements_PR_EN_Final
Grafico Azioni Valneva (EU:VLA)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Valneva (EU:VLA)
Storico
Da Apr 2023 a Apr 2024